US Stock MarketDetailed Quotes
ICCM Icecure Medical
- 0.626
- -0.013-2.10%
Close Sep 6 16:00 ET
31.00MMarket Cap-2158P/E (TTM)
0.670High0.626Low118.37KVolume0.650Open0.640Pre Close75.63KTurnover0.52%Turnover RatioLossP/E (Static)49.52MShares1.57052wk High2.93P/B14.21MFloat Cap0.52052wk Low--Dividend TTM22.69MShs Float16.000Historical High--Div YieldTTM6.90%Amplitude0.520Historical Low0.638Avg Price1Lot Size
Icecure Medical Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 40.49%-2.36M | 2.89%-2.85M | 12.39%-12.52M | 35.95%-2.64M | 10.55%-2.97M | -4.91%-3.97M | 4.02%-2.94M | -13.38%-14.29M | 29.96%-4.13M | -5.37%-3.32M |
| Net income from continuing operations | 20.78%-3.08M | 4.22%-3.61M | 13.70%-14.65M | 24.22%-3M | 1.43%-4M | 13.98%-3.89M | 15.27%-3.77M | -71.58%-16.98M | -25.06%-3.95M | -40.51%-4.06M |
| Operating gains losses | -60.00%36K | 437.50%43K | -106.96%-25K | -93.22%-228K | 223.53%105K | -82.00%90K | -87.10%8K | 7,080.00%359K | -71.01%-118K | -269.57%-85K |
| Depreciation and amortization | 3.80%82K | 7.59%85K | 30.24%323K | 12.16%83K | 17.14%82K | 51.92%79K | 51.92%79K | 95.28%248K | 80.49%74K | 94.44%70K |
| Change In working capital | 300.45%443K | -1.03%384K | 144.39%523K | 129.97%193K | -43.01%163K | 11.95%-221K | -52.86%388K | 106.78%214K | 76.73%-644K | 182.90%286K |
| -Change in receivables | -772.00%-168K | 16.92%-54K | -106.61%-25K | -95.76%5K | 183.33%10K | -90.46%25K | -750.00%-65K | 204.42%378K | 131.98%118K | -271.43%-12K |
| -Change in inventory | -19.77%142K | 330.99%164K | 164.52%582K | 333.33%371K | 323.40%105K | 154.13%177K | 80.76%-71K | -1.23%-902K | 12.15%-159K | 84.79%-47K |
| -Change in prepaid assets | -57.40%118K | -86.10%52K | -52.76%496K | 125.04%161K | -177.83%-316K | -50.45%277K | -48.63%374K | 151.72%1.05M | 64.20%-643K | 409.92%406K |
| -Change in payables and accrued expense | 212.12%37K | 637.93%156K | -26.95%-212K | -659.82%-627K | 242.39%477K | -112.36%-33K | 86.26%-29K | -170.76%-167K | 166.67%112K | -1,057.14%-335K |
| -Change in other current assets | 328.57%60K | 56.25%75K | -25.71%182K | -21.95%64K | -17.65%56K | -78.79%14K | 65.52%48K | 140.36%245K | -29.31%82K | 109.16%68K |
| -Change in other current liabilities | 137.30%254K | -106.87%-9K | -28.21%-500K | 242.21%219K | -182.04%-169K | 36.83%-681K | -79.40%131K | -178.63%-390K | 73.45%-154K | -74.09%206K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 40.49%-2.36M | 2.89%-2.85M | 12.39%-12.52M | 35.95%-2.64M | 10.55%-2.97M | -4.91%-3.97M | 4.02%-2.94M | -13.38%-14.29M | 29.96%-4.13M | -5.37%-3.32M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -156.28%-843K | 103.25%491K | 19.98%-713K | 440.27%9.06M | 74.94%3.85M | 132.38%1.5M | -10,400.00%-15.12M | -123.50%-891K | 1,036.31%1.68M | 2,139.81%2.2M |
| Net PPE purchase and sale | 91.67%-6K | 88.80%-28K | 46.13%-480K | 19.00%-81K | 74.16%-77K | 79.37%-72K | -73.61%-250K | -67.17%-891K | 43.82%-100K | -175.93%-298K |
| Net investment purchase and sale | -153.31%-837K | 103.56%529K | ---529K | 397.75%8.84M | 57.18%3.93M | 136.71%1.57M | ---14.87M | --0 | 502.03%1.78M | --2.5M |
| Net other investing changes | --0 | ---10K | --296K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -156.28%-843K | 103.25%491K | 19.98%-713K | 440.27%9.06M | 74.94%3.85M | 132.38%1.5M | -10,400.00%-15.12M | -123.50%-891K | 1,036.31%1.68M | 2,139.81%2.2M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1.89M | 2.84M | -99.39%83K | -99.50%68K | 15K | 0 | 0 | -56.05%13.58M | -16.40%13.58M | 0 |
| Net common stock issuance | --1.89M | --2.84M | --0 | ---- | ---- | --0 | --0 | -55.57%13.58M | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | 4,050.00%83K | 6,700.00%68K | ---- | ---- | ---- | -99.41%2K | -99.70%1K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --1.89M | --2.84M | -99.39%83K | -99.50%68K | --15K | --0 | --0 | -56.05%13.58M | -16.40%13.58M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 96.03%10.97M | -55.48%10.53M | -7.66%23.66M | -69.24%3.83M | -77.49%3.03M | -74.98%5.59M | -7.66%23.66M | 631.61%25.62M | -19.16%12.44M | -27.64%13.47M |
| Current changes in cash | 46.79%-1.32M | 102.64%476K | -718.87%-13.15M | -41.76%6.48M | 180.65%900K | 70.59%-2.47M | -463.58%-18.06M | -107.27%-1.61M | 9.41%11.12M | 65.67%-1.12M |
| Effect of exchange rate changes | 102.22%2K | -437.50%-43K | 107.02%25K | 132.65%228K | -223.53%-105K | 81.13%-90K | 87.10%-8K | -927.91%-356K | 42.03%98K | 269.57%85K |
| End cash Position | 218.44%9.65M | 96.03%10.97M | -55.48%10.53M | -55.48%10.53M | -69.24%3.83M | -77.49%3.03M | -74.98%5.59M | -7.66%23.66M | -7.66%23.66M | -19.16%12.44M |
| Free cash flow | 41.40%-2.37M | 9.63%-2.88M | 14.37%-13M | 35.55%-2.73M | 15.79%-3.05M | 2.20%-4.04M | 0.53%-3.19M | -15.57%-15.18M | 30.37%-4.23M | -11.02%-3.62M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg